SCHEMBL16416020

SCHEMBL16416020

CCc1nc(C)nn1CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15157117 0.78 L3MBTL1 (0.34) —
SCHEMBL21960147 0.77 ADORA2A (0.33) —
SCHEMBL16416319 0.72 ALDH1A1 (0.46) —
SCHEMBL16416048 0.69 — —
SCHEMBL12344045 0.66 — —
SCHEMBL29954122 0.65 ALDH1A1 (0.33) —
SCHEMBL18965032 0.64 — —
SCHEMBL9342106 0.64 — —
SCHEMBL13072298 0.64 CYP19A1 (0.46) —
SCHEMBL15332973 0.63 MEN1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3024832-A1 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2016-06-01 — — EP claimed
WO-2015011099-A1 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2015-01-29 — — WO claimed
EP-3024832-A1 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2016-06-01 — — EP disclosed
WO-2015011099-A1 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2015-01-29 — — WO disclosed
Send feedback